A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)
2014 ◽
Vol 8
(1)
◽
pp. 132-141
◽
Keyword(s):
2008 ◽
Vol 2008
◽
pp. 323-324
Keyword(s):
Keyword(s):
1998 ◽
Vol 3
(3)
◽
pp. 125-135
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 25
(2)
◽
pp. 133-138
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 78
(Meeting Abstracts 1)
◽
pp. P05.003-P05.003
Keyword(s):